Human Molecular Genetics Advance Access published online on August 12, 2003
Human Molecular Genetics, doi:10.1093/hmg/ddg271
© 2003 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Developmental and Cell Biology, 4244 McGaugh Hall, University of California, Irvine, CA 92697-2300, USA
* To whom correspondence should be addressed. E-mail: jlmarsh{at}uci.edu.
Can Drosophila models be engineered that accurately reflect Huntington's disease [HD] and other neurological diseases and can they contribute to the search for treatments and cures? A number of publications seem to provide a resounding yes to that question. Here we seek to review some of the salient features of these models. Key Words:
Drosophila, polyglutamine, Huntington's disease, neurodegeneration
Article
FLY MODELS OF HUNTINGTON'S DISEASE
2 Department of Psychiatry and Human Behavior, Gillespie 2121, University of California, Irvine, CA 92697-4260, USA
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J.-C. Lievens, T. Rival, M. Iche, H. Chneiweiss, and S. Birman Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila Hum. Mol. Genet., March 1, 2005; 14(5): 713 - 724. [Abstract] [Full Text] [PDF] |
||||
